You haven't searched anything yet.
Role Title: Director of Manufacturing
Department: Manufacturing
Supervisor: COO and CEO
FLSA: Exempt
CORE VALUES
Respect ● Passion ● Teamwork ● Integrity ● Honesty ● Commitment ● Collaboration
ROLE SUMMARY
The MSAT Senior Process Engineer (Upstream), under minimal supervision, is responsible for overseeing the development, transfer, validation, and troubleshooting of Polaris’ bio-pharmaceutical processes as well as other process of potential CDMO projects. The MSAT engineer is expected to serve as a Subject Matter Expert (SME) for a wide variety of process steps and equipment, with emphasis on Upstream manufacutring. Experience with process development, technology transfer, process validation, and cGMP bio-manufacturing are highly desired. Ability to plan, coordinate, and execute large-scale projects related to the manufacturing process is required. As part of the MSAT group, the Engineer must have a strong understanding of Upstream manufacturing processes to assist with process development and technology transfer. Ability to assist with/support routine manufacturing activities may be required.
ROLE RESPONSIBILITIES
SKILLS
QUALIFICATIONS
B. S./B. A. in Engineering/Science Related Field. 8-12 years of relevant cGMP experience is desired.
MS Degree in Engineering/Science Related Field. 5-9 years of relevant cGMP experience is desired.
PhD in Engineering/Science Related Field. 3-6 years of relevant cGMP experience is desired.
Full Time
$118k-140k (estimate)
06/25/2024
07/13/2024
polarispharma.com
SAN DIEGO, CA
25 - 50
2006
BOR WEN WU
$5M - $10M
Pharmaceutical
Polaris Group, a privately held multinational biopharmaceutical drug company, specializes in the research and development of protein drugs to treat cancer and other debilitating diseases in humans. Polaris' lead project is ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma. Polaris is collaborating with EnzymeRx in the development of Uricase-PEG 20 for the treatment of gout, tumor lysis syndrome, and other diseases related to hyperuricemia. Polaris is also researching and developing other biotherapeu...tic agents and has a small molecule drug program. The latter utilizes a rational structure-based approach for the design of novel compounds that inhibit the biological function of cancer-related protein targets.
More
Show less